|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.37 MYR | -2.63% |
|
-3.90% | -3.90% |
| 05/06 | Pharmaniaga Shareholders OK Renewal of Share Buyback, Transaction Mandates | MT |
| 27/05 | Pharmaniaga Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Pharmaniaga Berhad reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was MYR 964.96 million compared to MYR 880.45 million a year ago. Net income was MYR 25.65 million compared to MYR 2.65 million a year ago.
Basic earnings per share from continuing operations was MYR 0.0178 compared to MYR 0.002 a year ago. Diluted earnings per share from continuing operations was MYR 0.0178 compared to MYR 0.002 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.90% | 113M | |
| +29.12% | 76.68B | |
| -0.13% | 24.41B | |
| +11.60% | 8.48B | |
| -25.74% | 7.47B | |
| +14.29% | 5.21B | |
| -0.34% | 4.12B | |
| -10.28% | 3.86B | |
| -5.96% | 3.56B | |
| +12.86% | 3.4B |
PHARMANIAGA 
